Denali Therapeutics Inc. (DNLI) Earnings
|
Expand Research on DNLI
| Next EPS Date | 11/11/26 | EPS Growth Rate | N/A |
|---|---|---|---|
| Average EPS % Beat Rate | -1.7% | Revenue Growth Rate | N/A |
| Average % Move 1-Wk after EPS | +3.5% | Normal Earnings Time | After Close |
| Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
|---|---|---|---|---|---|---|---|---|---|---|---|
11/11/26  |
Q326 | N/A | -$0.39 | N/A | N/A | $12.31M | N/A | N/A | N/A | ||
| 8/6/26 |
Q226 | -$0.68 | -$0.64 | -$0.04 | $3.6M | $11.94M | N/A |  | | Details | |
| 5/7/26 |
Q126 | -$0.69 | -$0.66 | -$0.03 | N/A | $17.96M | N/A | | | Details | |
| 3/26/26 |
Q425 | -$0.73 | -$0.75 | +$0.02 | N/A | $6.92M | N/A | | | Details | |
| 3/2/26 |
Q425 | N/A | -$0.75 | N/A | N/A | $6.92M | N/A | N/A | N/A | ||
| 11/6/25 |
Q325 | -$0.74 | -$0.75 | +$0.01 | N/A | $1.36M | N/A | | | Details | |
| 11/3/25 |
Q325 | N/A | -$0.75 | N/A | N/A | $1.36M | N/A | N/A | N/A | ||
| 10/30/25 |
Q325 | N/A | -$0.75 | N/A | N/A | $1.36M | N/A | N/A | N/A |
